Xceptor Cbd Pain
FDA Label NDC 72519-103

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Xceptor Llc for the product Xceptor Cbd Pain (NDC 72519-103). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

TEA SALICYLATE  10%

Purpose

TOPICAL ANALGESIC

Uses

TOPICAL PAIN RELIEF FOR MINOR ACHES AND PAINS.

Warnings

FOR EXTERNAL USE ONLY.

KEEP AWAY FROM EYES.

Otc - Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN.

Directions

APPLY SMALL AMOUNT TO AFFECTED AREA AND RUB IN. ADD AS NEEDED.

Other Information

STORE AT 20° - 25°C (68°-77°F)

Inactive Ingredients

ALOE BARBADENSIS LEAF JUICE EXTRACT, BENZOIC ACID, BENZYL ALCOHOL, BETA VULGARIS (BEET) ROOT EXTRACT, CANNABIDIOL FROM HEMP, COCOCAPRYLATE/CAPRATE, COCOS NUCIFERA (COCONUT) OIL, COCONUT ALKANES, CYCLODEXTRIN, DISTEARDIMONIUM HECTORITE, GLYCERIN, LAVENDER (ESSENTIAL) OIL, MAGNESIUM SULFATE, POLYGLYCERYL-3 DIISOSTEARATE, POLYGLYCERYL-3 POLYRICINOLEATE, SHEA BUTTER ETHYL ESTERS, SORBIC ACID, TREMELLA FUCIFORMIS SPOROCARP EXTRACT, XANTHAN GUM, WATER

Questions / Comments?

PLEASE CALL US AT (760) 710-0510

Package Label.Principal Display Panel

* Please review the disclaimer below.